Jim Cramer Says Abbott Laboratories (ABT)'s a 'Great Company' Despite the Ongoing Lawsuits

By Yahoo! Finance | Aug 27, 2024 at 01:23 PM EST

A recent analysis delves into Abbott Laboratories' position among stocks that caught Jim Cramer's attention. Despite ongoing lawsuits, Abbott's strong financials, product launches, and growth in the medical sector have garnered positive analyst sentiment and a price target upgrade.

Did you find this insightful?

Bad

Just Okay

Amazing

We are preparing, please wait

New Alert

Select an alert type

Sentiment Spike

Send email alert if news sentiment changes significantly

Mentions Spike

Send email alert if has a surge in mentions

Choose sentiment spike or mentions spike or both to receive email alerts and app notification for the selected stock.
Note: Please be aware that you will receive an email only once a day, around 8:00 AM (EST), in the event of any spike.
In future if you don't want to receive any email then delete stocks added into alert section.